As a biopharmaceutical company, the Chiesi Group collaborates closely with the scientific community, fostering a dynamic exchange of knowledge that has yielded significant advancements in the scientific realm. Our commitment is directed towards enhancing patient health while adhering to the established codes and regulations governing our sector.
In compliance with the Code on Disclosure of Transfers of Value from Pharmaceutical Companies to Healthcare Professionals and Healthcare Organizations, issued by EFPIA - European Federation of Pharmaceutical Industries - and acknowledged in the Farmindustria Code of Conduct, we transparently report annually on relevant data at European level since 2015, with the first publication on June 30th, 2016.
Here below on the Chiesi Farmaceutici S.p.A. it is provided a detailed report of any financial transactions made in 2022 towards Healthcare Professionals and Healthcare Organizations.
Report 2022
Archive
Which transactions are encompassed?
Healthcare Professionals:
Expenses related to attending conferences and congresses.
Expenditure for consultancy work and professional services, regulated by specific contracts.
Healthcare Organizations:
Donations and contributions, in the form of money or in kind, supporting scientific events for specialized training.
Funding for consultancy work and professional services covered by a written agreement between Chiesi and other institutions, organizations, or associations.
For detailed information on the regulations outlined in the "Code on Disclosure of Transfers of Value from Pharmaceutical Firms, Healthcare Professionals, and Organizations", please click here or contact the Chiesi Transparency Contact Point at the following email address:
dpoit@chiesi.com (Chiesi Transparency Contact Point)
If you are a journalist or a freelance, please Contact